Cannabis Clinical Trials

Visit the Therapix Biosciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess the Effect of TXH-TS01 in Patients with Tourette Syndrome TEL AVIV, Israel, May 8, 2017 /PRNewswire/ — […]

Image Courtesy of Chloe Sommers Colorado adds another unique endeavor to its list of innovative and cutting-edge cannabis work with the first annual Institute of Cannabis Research (ICR) conference at Colorado State University in Pueblo. The Institute has partnerships with CSU Pueblo, the state of Colorado, and Pueblo County. The academically-focused ICR 2017 conference took […]

Axim Biotechnologies recently announced that its U.K. partner, Quay Pharmaceuticals, has secured licenses from the British Home Office to continue developing and importing its medical cannabinoid product MedChew Rx — a potential treatment for pain and spasticity in people with multiple sclerosis (MS), among other illnesses. MedChew Rx is a gum containing 5 mg of cannabidiol (CBD) and 5 mg of […]

The Canadian Forces and Veterans Affairs are setting up a clinical trial to evaluate the safety and efficacy of using medical marijuana to treat post-traumatic stress disorder in military members and veterans. A briefing note to the veterans affairs minister from October reveals a senior psychiatrist with the Canadian Forces “has drafted a preliminary protocol to […]

NANAIMO, British Columbia–(BUSINESS WIRE)– Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to […]

SEATTLE, WA–(Marketwired – May 4, 2017) – CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview and article discussing Tetra Bio-Pharma Inc. ( CSE : TBP ) ( OTCQB : GRPOF ) and its transition to a pharmaceutical-like approach to the cannabis […]